# FDA recall D-616-2013

> **Hospira Inc.** · Class II · drug recall initiated 2012-05-04.

## Product

20% Dextrose Injection, USP, a) 500 mL in 1000 mL Partial-Fill Container (NDC 0409-7935-19), b) 500 mL VisIV Container (NDC 0409-7953-30), c) 1000 mL VisIV Container, (NDC 0409-7953-48), Rx Only, Hospira, Inc., Lake Forest, IL 60045

## Reason for recall

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

## Distribution

Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia

## Key facts

- **Recall number:** D-616-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-05-04
- **Report date:** 2013-07-03
- **Termination date:** 2015-07-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-616-2013

## Citation

> AI Analytics. FDA recall D-616-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-616-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*